BCRX

6:33 am BioCryst Pharm announces Nature publication demonstrating efficacy of BCX4430 in a non-human primate model of filovirus infection; broad spectrum activity shown against multiple RNA virus biothreats

moreView todays social media effects on BCRXView the latest stocks trending across Twitter. Click to view dashboardSee who BioCryst is hiring next, click here to view […]

BioCryst Presents BCX4161 Phase 1 Trial and Kallikrein Inhibition Assay Results

[GlobeNewswire] – RESEARCH TRIANGLE PARK, N.C. — BioCryst Pharmaceuticals, Inc. announced the presentation of two scientific posters today at the American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting … moreView todays social media effects on BCRXView the latest stocks trending across Twitter. Click to view dashboardSee who BioCryst is hiring next, click here to view […]

BioCryst Pharmaceuticals’ CEO Discusses Q4 2013 Results – Earnings Call Transcript

[at Seeking Alpha] – Jon Stonehouse Thank you, Rob. Good morning and thanks to everyone for joining us today. moreView todays social media effects on BCRXView the latest stocks trending across Twitter. Click to view dashboardSee who BioCryst is hiring next, click here to view […]

BioCryst Pharmaceuticals, Inc. Discusses Q4 2013 Results (Webcast)

[at Seeking Alpha] – The following audio is from a conference call that will begin on February 26, 2014 at 11:00 AM ET. The audio will stream live while the call is active, and can be replayed upon its completion. moreView todays social media effects on BCRXView the latest stocks trending across Twitter. Click to view dashboardSee who BioCryst is […]

BioCryst Reports Fourth Quarter and Full Year 2013 Financial Results

[GlobeNewswire] – RESEARCH TRIANGLE PARK, N.C. — BioCryst Pharmaceuticals, Inc. today announced financial results for the fourth quarter and full year ended December 31, 2013. moreView todays social media effects on BCRXView the latest stocks trending across Twitter. Click to view dashboardSee who BioCryst is hiring next, click here to view […]